Maynard Um
-
-
-
-
-
-
-
enVVeno Medical Secures Transformational U.S. Patent for enVVe System, Strengthening Competitive Moat Ahead of Launch of Historic FDA Pivotal Trial
-
-
-
-
-
-
-
enVVeno Medical gets FDA approval for venous valve study
-
-
-
-
-
-
-
enVVeno Medical (NASDAQ:NVNO) to Participate in a Live Virtual Investor CEO Connect Segment
-
-
-
-
-
-
-
enVVeno Medical Updates Regulatory Status of VenoValve(R)
-
-
-
-
-
-
-
Health Economic Study Shows That enVVeno Medical's VenoValve(R) Would be a Cost-Effective Treatment Option for Patients with Severe Chronic Venous Insufficiency
-
-
-
-
-
-
-
enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer
-
-
-
-
-
-
-
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
-
431,615 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

